Who has invested in Ocumension Therapeutics?

No investors are named on the public record for Ocumension Therapeutics yet.

Ocumension Therapeutics Funding: $200M Raised, IPO (2020)

Ocumension Therapeutics funding overview

Ocumension Therapeutics is based in Suzhou, China. Ocumension Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in July 2020. The round record for Ocumension Therapeutics runs through 2020; nothing later has been disclosed.

Ocumension Therapeutics at a glance

Total raised: $200M
Latest round: IPO
Latest round date: July 2020
Headquarters: Suzhou, China

Frequently asked about Ocumension Therapeutics funding

How much has Ocumension Therapeutics raised?: Ocumension Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Ocumension Therapeutics?: No investors are named on the public record for Ocumension Therapeutics yet.
What was the latest Ocumension Therapeutics funding round?: The most recent disclosed round is an IPO, announced in July 2020.
Where is Ocumension Therapeutics based?: Ocumension Therapeutics is based in Suzhou, China.
When did Ocumension Therapeutics last raise?: The last disclosed Ocumension Therapeutics round closed in July 2020 at IPO.

Ocumension Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.

Ocumension Therapeutics Funding: $200M Raised, IPO (2020)

Ocumension Therapeutics funding overview

Ocumension Therapeutics at a glance

Frequently asked about Ocumension Therapeutics funding

Companies related to Ocumension Therapeutics (18)

Browse related funding lists (3)